1 | 1 | | 2025 |
---|
2 | 2 | | STATE OF WYOMING |
---|
3 | 3 | | 25LSO-03761HB0152 |
---|
4 | 4 | | HOUSE BILL NO. HB0152 |
---|
5 | 5 | | Donated blood-mRNA disclosure. |
---|
6 | 6 | | Sponsored by: Representative(s) McCann, Allemand, Angelos, |
---|
7 | 7 | | Heiner, Locke, Ottman, Pendergraft, |
---|
8 | 8 | | Rodriguez-Williams, Smith, S, Styvar and |
---|
9 | 9 | | Wasserburger and Senator(s) Hutchings, |
---|
10 | 10 | | Pearson and Steinmetz |
---|
11 | 11 | | A BILL |
---|
12 | 12 | | for |
---|
13 | 13 | | 1 AN ACT relating to public health and safety; requiring |
---|
14 | 14 | | 2 blood donors to disclose vaccination status as specified; |
---|
15 | 15 | | 3 requiring blood packaging to be marked as specified; |
---|
16 | 16 | | 4 allowing a person who receives a blood transfusion to |
---|
17 | 17 | | 5 request the use of certain blood; providing definitions; |
---|
18 | 18 | | 6 requiring rulemaking; and providing for an effective date. |
---|
19 | 19 | | 7 |
---|
20 | 20 | | 8 |
---|
21 | 21 | | 9 |
---|
22 | 22 | | 10. W.S. 35-4-1101 is created to read: |
---|
23 | 23 | | 11 |
---|
24 | 24 | | 12 ARTICLE 11 |
---|
25 | 25 | | 13 BLOOD DONATIONS AND VACCINATIONS |
---|
26 | 26 | | 14 2025STATE OF WYOMING25LSO-03762HB01521 |
---|
27 | 27 | | 2 |
---|
28 | 28 | | 3 |
---|
29 | 29 | | 4 |
---|
30 | 30 | | 5 (a) As used in this chapter: |
---|
31 | 31 | | 6 |
---|
32 | 32 | | 7 (i) "COVID-19" means as defined in W.S. |
---|
33 | 33 | | 8 1-1-141(a)(ii); |
---|
34 | 34 | | 9 |
---|
35 | 35 | | 10 (ii) "Messenger ribonucleic acid vaccine" means |
---|
36 | 36 | | 11 a type of vaccine that uses called messenger ribonucleic |
---|
37 | 37 | | 12 acid to produce an immune response against a disease. |
---|
38 | 38 | | 13 |
---|
39 | 39 | | 14 (b) Any person who collects human blood donations for |
---|
40 | 40 | | 15 the purpose of providing blood for human blood transfusion |
---|
41 | 41 | | 16 shall require blood donors to disclose whether the blood |
---|
42 | 42 | | 17 donor has received a COVID-19 vaccine or a messenger |
---|
43 | 43 | | 18 ribonucleic acid vaccine at any time. |
---|
44 | 44 | | 19 |
---|
45 | 45 | | 20 (c) Blood originating from a donor who has received a |
---|
46 | 46 | | 21 COVID-19 vaccine or a messenger ribonucleic acid vaccine |
---|
47 | 47 | | 22 shall be conspicuously marked on the packaging of the blood |
---|
48 | 48 | | 23 and any paperwork related to the blood. 2025STATE OF WYOMING25LSO-03763HB01521 |
---|
49 | 49 | | 2 (d) In a nonemergency situation, as determined by the |
---|
50 | 50 | | 3 health care provider providing medical services, a person |
---|
51 | 51 | | 4 receiving a blood transfusion shall have the right to |
---|
52 | 52 | | 5 request blood based on whether or not the blood originated |
---|
53 | 53 | | 6 from a person who has received a COVID-19 vaccine or a |
---|
54 | 54 | | 7 messenger ribonucleic acid vaccine, if the requested blood |
---|
55 | 55 | | 8 is available at the facility. |
---|
56 | 56 | | 9 |
---|
57 | 57 | | 10. The department of health shall promulgate |
---|
58 | 58 | | 11 all rules necessary to implement this act. |
---|
59 | 59 | | 12 |
---|
60 | 60 | | 13. This act is effective July 1, 2025 |
---|
61 | 61 | | 14 |
---|
62 | 62 | | 15 (END) |
---|